PreciThera raises C$36M series A

Orphan bone disease newco PreciThera Inc. (Montreal, Canada) raised C$36 million ($28.6 million) on July 27 in an oversubscribed series A round led by Arix Bioscience. Sanderling Ventures, Fonds de s...